Related Experiment Video
Updated: Aug 14, 2026

Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates
Published on: February 27, 2016
Comparative Structure-Based Analysis of Predicted BZD9L1 Binding Modes Across Human Sirtuins
Yi Jer Tan1,2, Yeuan Ting Lee1, Chern Ein Oon1
1Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang 11800, Malaysia.
This study investigates BZD9L1, a sirtuin (SIRT) inhibitor, across all human SIRT isoforms using computational modeling and experiments. Findings suggest BZD9L1 interacts with multiple SIRT isoforms, guiding future inhibitor development for cancer and other diseases.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- Sirtuins (SIRTs) are NAD+-dependent enzymes crucial in cellular processes, but their conserved catalytic sites hinder selective inhibitor design.
- BZD9L1, a benzimidazole derivative, is a known inhibitor of SIRT1 and SIRT2, yet its interactions with other SIRT isoforms are not fully understood.
Purpose of the Study:
- To computationally model and experimentally assess the binding interactions of BZD9L1 across all seven human sirtuin isoforms (SIRT1-7).
- To provide structural hypotheses for BZD9L1 recognition by sirtuins and guide the development of isoform-selective inhibitors.
Main Methods:
- Utilized a structure-based modeling framework including homology modeling and molecular docking to predict BZD9L1 binding modes across SIRT1-7.
- Conducted targeted experimental assessments, including cellular assays (acetyl-SOD2 levels) and cell-free enzymatic assays (SIRT5 inhibition).
Main Results:
- Molecular docking predicted BZD9L1 binding to the cofactor-binding region of all SIRT isoforms, with conserved orientations but varying interaction networks (hydrogen bonds, pi-stacking, hydrophobic contacts).
- Cellular assays indicated BZD9L1 alters SIRT3-associated deacetylation in colorectal cancer cells.
- Cell-free assays showed no measurable SIRT5 inhibition under tested conditions, suggesting isoform-specific activity.
Conclusions:
- BZD9L1 interacts with multiple human sirtuin isoforms, albeit with distinct predicted binding features.
- The study provides structural insights and testable hypotheses for BZD9L1-sirtuin interactions, crucial for designing targeted cancer therapies.
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding and Linkage
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
